More than £30 million is to be spent on expanding Croda International’s manufacturing facilities for a vital vaccine ingredient.
The East Yorkshire giant is set to significantly enhance its facilities in Leek, Staffordshire, where specific production is based, expanding the range and capacity.
It will also provide a base for future work in cancer and heart disease. Government is supporting the huge investment, with match-funding of £15.9 million.
